Arlington Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.52M Buy
51,862
+2,317
+5% +$202K 1.67% 23
2025
Q1
$4.45M Buy
49,545
+10,586
+27% +$951K 1.75% 23
2024
Q4
$3.11M Sell
38,959
-10,232
-21% -$817K 1.21% 48
2024
Q3
$4.43M Buy
49,191
+9,643
+24% +$868K 1.73% 16
2024
Q2
$3.11M Buy
39,548
+4,430
+13% +$349K 1.55% 47
2024
Q1
$3.06M Buy
35,118
+27,472
+359% +$2.39M 1.56% 37
2023
Q4
$630K Buy
+7,646
New +$630K 0.18% 68
2023
Q2
Sell
-38,407
Closed -$3.1M 624
2023
Q1
$3.1M Buy
38,407
+5,152
+15% +$415K 0.44% 19
2022
Q4
$2.58M Buy
33,255
+549
+2% +$42.7K 0.41% 25
2022
Q3
$2.64M Buy
32,706
+4,455
+16% +$360K 1.06% 21
2022
Q2
$2.54M Buy
28,251
+1,882
+7% +$169K 0.84% 23
2022
Q1
$2.93M Buy
26,369
+6,014
+30% +$667K 0.83% 22
2021
Q4
$2.11M Sell
20,355
-1,078
-5% -$112K 0.57% 41
2021
Q3
$2.69M Buy
21,433
+3,041
+17% +$381K 0.77% 30
2021
Q2
$2.28M Buy
18,392
+235
+1% +$29.2K 0.79% 29
2021
Q1
$2.15M Buy
18,157
+1,389
+8% +$164K 0.79% 27
2020
Q4
$1.96M Buy
16,768
+15
+0.1% +$1.76K 0.9% 23
2020
Q3
$1.74M Sell
16,753
-31
-0.2% -$3.22K 0.95% 26
2020
Q2
$1.54M Buy
16,784
+1,769
+12% +$162K 0.86% 29
2020
Q1
$1.35M Buy
15,015
+12,066
+409% +$1.09M 0.7% 27
2019
Q4
$335K Buy
2,949
+235
+9% +$26.7K 0.21% 42
2019
Q3
$295K Sell
2,714
-11,771
-81% -$1.28M 0.19% 40
2019
Q2
$1.41M Buy
+14,485
New +$1.41M 0.63% 36
2018
Q3
Sell
-10,219
Closed -$875K 222
2018
Q2
$875K Buy
+10,219
New +$875K 0.83% 28
2018
Q1
Sell
-10,044
Closed -$811K 140
2017
Q4
$811K Buy
+10,044
New +$811K 0.84% 32